Bigdeli, Tim B. https://orcid.org/0000-0003-2215-5946
Chatzinakos, Chris
Bendl, Jaroslav https://orcid.org/0000-0001-9989-2720
Barr, Peter B. https://orcid.org/0000-0001-9321-657X
Venkatesh, Sanan
Gorman, Bryan R. https://orcid.org/0000-0002-4239-4672
Clarence, Tereza
Genovese, Giulio https://orcid.org/0000-0003-3066-5575
Iyegbe, Conrad O.
Peterson, Roseann E. https://orcid.org/0000-0001-6402-849X
Kolokotronis, Sergios-Orestis https://orcid.org/0000-0003-3309-8465
Burstein, David
Meyers, Jacquelyn L.
Li, Yuli
Natarajan, Sundar
Francis, Michael O. https://orcid.org/0000-0002-1320-7161
Rajeevan, Nallakkandi
Cheung, Kei-Hoi
,
,
,
DeLisi, Lynn E.
Kosten, Thomas R. https://orcid.org/0000-0003-1505-555X
Zhao, Hongyu https://orcid.org/0000-0003-1195-9607
Achtyes, Eric https://orcid.org/0000-0001-8939-1535
Buckley, Peter F.
Malaspina, Dolores
Lehrer, Douglas
Rapaport, Mark H.
Braff, David L.
Pato, Michele T.
Fanous, Ayman H.
Pato, Carlos N.
,
,
,
Huang, Grant D.
Muralidhar, Sumitra https://orcid.org/0000-0001-8417-9068
Gaziano, J. Michael
Pyarajan, Saiju https://orcid.org/0000-0002-9047-3762
Girdhar, Kiran https://orcid.org/0000-0002-5622-042X
Lee, Donghoon https://orcid.org/0000-0003-0453-6059
Hoffman, Gabriel E. https://orcid.org/0000-0002-0957-0224
Aslan, Mihaela
Fullard, John F. https://orcid.org/0000-0001-9874-2907
Voloudakis, Georgios https://orcid.org/0000-0002-5729-632X
Harvey, Philip D.
Roussos, Panos https://orcid.org/0000-0002-4640-6239
Article History
Received: 24 August 2024
Accepted: 3 December 2025
First Online: 21 January 2026
Competing interests
: P.D.H. has served as a consultant to several pharmaceutical companies and device manufacturers on phase 2 or 3 development; this consulting work has been determined to be unrelated to the content of the paper. The remaining authors declare no competing interests.